BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 32814228)

  • 21. Longitudinal diffusion tensor imaging in dementia with Lewy bodies and Alzheimer's disease.
    Firbank MJ; Watson R; Mak E; Aribisala B; Barber R; Colloby SJ; He J; Blamire AM; O'Brien JT
    Parkinsonism Relat Disord; 2016 Mar; 24():76-80. PubMed ID: 26792342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-Linear Association between Cerebral Amyloid Deposition and White Matter Microstructure in Cognitively Healthy Older Adults.
    Wolf D; Fischer FU; Scheurich A; Fellgiebel A;
    J Alzheimers Dis; 2015; 47(1):117-27. PubMed ID: 26402760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross-sectional Associations of β-Amyloid, Tau, and Cerebrovascular Biomarkers With Neurodegeneration in Probable Dementia With Lewy Bodies.
    Ferreira D; Przybelski SA; Lesnick TG; Schwarz CG; Diaz-Galvan P; Graff-Radford J; Senjem ML; Fields JA; Knopman DS; Jones DT; Savica R; Ferman TJ; Graff-Radford N; Lowe VJ; Jack CR; Petersen RC; Westman E; Boeve BF; Kantarci K
    Neurology; 2023 Feb; 100(8):e846-e859. PubMed ID: 36443011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathological Correlation: Dopamine and Amyloid PET Imaging with Neuropathology in Three Subjects Clinically Diagnosed with Alzheimer's Disease or Dementia with Lewy Bodies.
    Gupta HV; Beach TG; Mehta SH; Shill HA; Driver-Dunckley E; Sabbagh MN; Belden CM; Liebsack C; Dugger BN; Serrano GE; Sue LI; Siderowf A; Pontecorvo MJ; Mintun MA; Joshi AD; Adler CH
    J Alzheimers Dis; 2021; 80(4):1603-1612. PubMed ID: 33720879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regional multimodal relationships between tau, hypometabolism, atrophy, and fractional anisotropy in atypical Alzheimer's disease.
    Sintini I; Schwarz CG; Martin PR; Graff-Radford J; Machulda MM; Senjem ML; Reid RI; Spychalla AJ; Drubach DA; Lowe VJ; Jack CR; Josephs KA; Whitwell JL
    Hum Brain Mapp; 2019 Apr; 40(5):1618-1631. PubMed ID: 30549156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tongue muscle mass is associated with total grey matter and hippocampal volumes in Dementia with Lewy Bodies.
    Borda MG; Castellanos-Perilla N; Tovar-Rios DA; Ferreira D; Duque G; Aarsland D
    Arch Gerontol Geriatr; 2022; 100():104647. PubMed ID: 35134612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of hippocampal atrophy on the cognitive phenotype of dementia with Lewy bodies.
    Elder GJ; Mactier K; Colloby SJ; Watson R; Blamire AM; O'Brien JT; Taylor JP
    Int J Geriatr Psychiatry; 2017 Nov; 32(11):1182-1189. PubMed ID: 28425185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired Glymphatic Flow on Diffusion Tensor MRI as a Marker of Neurodegeneration in Alzheimer's Disease: Correlation with Gray Matter Volume Loss and Cognitive Decline Independent of Cerebral Amyloid Deposition.
    Kim M; Song YS; Han K; Bae YJ; Han JW; Kim KW
    J Alzheimers Dis; 2024; 99(1):279-290. PubMed ID: 38669532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterizing White Matter Tract Degeneration in Syndromic Variants of Alzheimer's Disease: A Diffusion Tensor Imaging Study.
    Madhavan A; Schwarz CG; Duffy JR; Strand EA; Machulda MM; Drubach DA; Kantarci K; Przybelski SA; Reid RI; Senjem ML; Gunter JL; Apostolova LG; Lowe VJ; Petersen RC; Jack CR; Josephs KA; Whitwell JL
    J Alzheimers Dis; 2016; 49(3):633-43. PubMed ID: 26484918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AV-1451 tau and β-amyloid positron emission tomography imaging in dementia with Lewy bodies.
    Kantarci K; Lowe VJ; Boeve BF; Senjem ML; Tosakulwong N; Lesnick TG; Spychalla AJ; Gunter JL; Fields JA; Graff-Radford J; Ferman TJ; Jones DT; Murray ME; Knopman DS; Jack CR; Petersen RC
    Ann Neurol; 2017 Jan; 81(1):58-67. PubMed ID: 27863444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An investigation of cerebrovascular lesions in dementia with Lewy bodies compared to Alzheimer's disease.
    Sarro L; Tosakulwong N; Schwarz CG; Graff-Radford J; Przybelski SA; Lesnick TG; Zuk SM; Reid RI; Raman MR; Boeve BF; Ferman TJ; Knopman DS; Comi G; Filippi M; Murray ME; Parisi JE; Dickson DW; Petersen RC; Jack CR; Kantarci K
    Alzheimers Dement; 2017 Mar; 13(3):257-266. PubMed ID: 27521790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
    Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
    Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. White matter changes in dementia with Lewy bodies and Alzheimer's disease: a tractography-based study.
    Kiuchi K; Morikawa M; Taoka T; Kitamura S; Nagashima T; Makinodan M; Nakagawa K; Fukusumi M; Ikeshita K; Inoue M; Kichikawa K; Kishimoto T
    J Psychiatr Res; 2011 Aug; 45(8):1095-100. PubMed ID: 21315376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer's Dementia.
    Schilling LP; Pascoal TA; Zimmer ER; Mathotaarachchi S; Shin M; de Mello Rieder CR; Gauthier S; Palmini A; Rosa-Neto P;
    Mol Neurobiol; 2019 Jul; 56(7):4916-4924. PubMed ID: 30414086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiating Dementia with Lewy Bodies and Alzheimer's Disease by Deep Learning to Structural MRI.
    Nemoto K; Sakaguchi H; Kasai W; Hotta M; Kamei R; Noguchi T; Minamimoto R; Arai T; Asada T
    J Neuroimaging; 2021 May; 31(3):579-587. PubMed ID: 33476487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Grey matter atrophy in prodromal stage of dementia with Lewy bodies and Alzheimer's disease.
    Blanc F; Colloby SJ; Cretin B; de Sousa PL; Demuynck C; O'Brien JT; Martin-Hunyadi C; McKeith I; Philippi N; Taylor JP
    Alzheimers Res Ther; 2016 Jul; 8():31. PubMed ID: 27484179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered whole-brain white matter networks in preclinical Alzheimer's disease.
    Fischer FU; Wolf D; Scheurich A; Fellgiebel A;
    Neuroimage Clin; 2015; 8():660-6. PubMed ID: 26288751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dementia with Lewy bodies: association of Alzheimer pathology with functional connectivity networks.
    Schumacher J; Gunter JL; Przybelski SA; Jones DT; Graff-Radford J; Savica R; Schwarz CG; Senjem ML; Jack CR; Lowe VJ; Knopman DS; Fields JA; Kremers WK; Petersen RC; Graff-Radford NR; Ferman TJ; Boeve BF; Thomas AJ; Taylor JP; Kantarci K
    Brain; 2021 Nov; 144(10):3212-3225. PubMed ID: 34114602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relevance of subcortical visual pathways disruption to visual symptoms in dementia with Lewy bodies.
    Delli Pizzi S; Maruotti V; Taylor JP; Franciotti R; Caulo M; Tartaro A; Thomas A; Onofrj M; Bonanni L
    Cortex; 2014 Oct; 59():12-21. PubMed ID: 25113955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multimodal MRI of grey matter, white matter, and functional connectivity in cognitively healthy mutation carriers at risk for frontotemporal dementia and Alzheimer's disease.
    Feis RA; Bouts MJRJ; Dopper EGP; Filippini N; Heise V; Trachtenberg AJ; van Swieten JC; van Buchem MA; van der Grond J; Mackay CE; Rombouts SARB
    BMC Neurol; 2019 Dec; 19(1):343. PubMed ID: 31881858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.